Patents by Inventor Christopher I. LEISKE

Christopher I. LEISKE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODULATION OF ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY
    Publication number: 20240173421
    Abstract: The present disclosure provides, inter alia, antibodies with covalently attached biocompatible polymeric moieties, that are useful in treating various diseases such as cancer and autoimmune disorders.
    Type: Application
    Filed: October 12, 2023
    Publication date: May 30, 2024
    Inventors: Philip MOQUIST, Matthew R. LEVENGOOD, Christopher I. LEISKE, Noah A. BINDMAN